Segment Data (Tables)

3 Months Ended

Mar. 31, 2026

Segment Reporting [Abstract]

Schedule of Segment Reporting Information by Reportable Segment

Net sales by product family were as follows:

	Three Months Ended
	March 31, 2026		March 28, 2025
Acthar Gel	$	169.5	$	115.4
Xiaflex (1)	134.4		—
INOmax	58.8		62.5
Amitiza	21.0		20.0
Other Products (1)	78.7		9.1
License Revenue (1)	5.9		0.2
Net sales	$	468.3	$	207.2

(1)Is or contains products acquired in the Business Combination. Accordingly, there are no comparable net sales for these products during the prior year period.